MabVax Therapeutics Holdings Inc(Other OTC/NBB : MBVX)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.38% | 194.91 | 1.2% | $602.16m | |
| GILD | Gilead Sciences, Inc. | -0.02% | 68.00 | 0.9% | $503.14m | |
| CELG | Celgene Corporation | -0.19% | 69.27 | 1.2% | $492.42m | |
| BIIB | Biogen Inc. | -0.09% | 318.94 | 1.3% | $467.20m | |
| ILMN | Illumina, Inc. | -0.53% | 300.00 | 3.5% | $379.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 339.00 | 2.6% | $298.68m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.45% | 161.07 | 1.9% | $260.54m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.00% | 115.06 | 2.0% | $199.08m | |
| A | Agilent Technologies, Inc. | -3.72% | 62.57 | 1.5% | $185.86m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 116.36 | 15.4% | $146.77m | |
| LGND | Ligand Pharmaceuticals Incorporated | -3.83% | 148.54 | 23.3% | $139.57m | |
| EXAS | Exact Sciences Corporation | 0.00% | 67.28 | 25.3% | $137.02m | |
| NKTR | Nektar Therapeutics | -0.05% | 37.99 | 5.6% | $122.18m | |
| INCY | Incyte Corporation | -3.40% | 64.25 | 2.5% | $115.74m | |
| TSRO | TESARO, Inc. | -0.41% | 36.68 | 14.4% | $108.95m |
Company Profile
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.